01494nam 2200409 450 991070477910332120130725065450.0(CKB)5470000002443931(OCoLC)853659517(EXLCZ)99547000000244393120130725d2013 ua 0engurmn|||||||||rdacontentrdamediardacarrierMedicare information on highest-expenditure Part B drugs : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives /statement of James Cosgrove[Washington, D.C.] :United States Government Accountability Office,2013.1 online resource (10 pages)Testimony ;GAO-13-739TTitle from title screen (viewed July 18, 2013)."For release ... June 28, 2013."Includes bibliographical references.Medicare MedicareEconomic aspectsDrugsPricesUnited StatesMedicareEconomic aspects.DrugsPricesCosgrove James C.1395889United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Health,United States.Government Accountability Office,GPOGPOBOOK9910704779103321Medicare3462118UNINA